Academy Helpdesk review
Every quarter, our Academies team will publish the most important and frequently asked helpdesk queries. You can download our 2024 quarterly updates here.
With a strong presence in Cambridge and offices based across London, the East of England, and internationally, pharmaceutical companies are a core sector for Price Bailey, with clients spanning all areas of the supply chain.
To support pharmaceutical companies, we have crafted our service offering to ensure that we can support you at whichever stage of your business lifecycle you find yourself.
The last couple of years has contained some of the greatest global challenges we have ever seen for numerous businesses, including pharmaceutical companies.
As a result, pharmaceutical companies have seen a rapid increase in demand to manufacture and deliver drugs to a market at an unprecedented speed. This, combined with regulatory changes, supply chain and skilled labour shortages around the world, has had a significant impact on pharmaceutical companies.
The speed at which pharmaceuticals can be brought to market is causing many to review their resources, operations, and strategies to prevent possible delays in their supply chains.
To alleviate some of the pressures that pharmaceutical companies may be facing and to allow you more headspace to focus on advancing your business, we can offer an extensive range of expert accountancy services.
Contact us today to find out more about how we can help you
Every quarter, our Academies team will publish the most important and frequently asked helpdesk queries. You can download our 2024 quarterly updates here.
Understand the VAT implications for doctors' practices, from exemptions to reclaiming VAT on taxable supplies. Essential insights for healthcare professionals.
Accounting and advisory firm Price Bailey unveils four new promotions and announces that two new appointments will be joining the Partnership team in the year ahead.
‘The biggest cash increase’ to the National Minimum Wage in over a decade has taken effect as of April 2024. Despite the benefits to workers whose wages will increase accordingly, GP practices are fearing that an increase in staff wages will not be met by a proportionate increase in funding for practices. Read our article to find out more.